Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Credit Suisse Downgrades Yiren Digital to Underperform

byVick Meyer

January 22, 2020

1 minute read

Credit Suisse analyst Yirendai Zhong downgrades Yiren Digital (NYSE:YRD) from Neutral to Underperform.

Raymond James Maintains Outperform on ConnectOne Bancorp, Lowers Price Target to $33

By Benzinga Newsdesk

Today, 5:13 AM

Raymond James analyst William Wallace maintains ConnectOne Bancorp (NASDAQ:CNOB) with a Outperform and lowers the price target from $38 to $33.

CNOB

KalVista Pharmaceuticals Announces Initiation Of KVD900 Phase 3 KONFIDENT Clinical Trial

By Benzinga Newsdesk

Today, 5:13 AM

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced the

KALV

Stifel Initiates Coverage On Travere Therapeutics with Hold Rating, Announces Price Target of $22

By Benzinga Newsdesk

Today, 5:13 AM

Stifel analyst Alex Thompson initiates coverage on Travere Therapeutics (NASDAQ:TVTX) with a Hold rating and announces Price Target of $22.

TVTX

Stifel Initiates Coverage On Vizsla Silver with Buy Rating, Announces Price Target of C$3.5

By Benzinga Newsdesk

Today, 5:13 AM

Stifel analyst Stephen Soock initiates coverage on Vizsla Silver (TSXV:VZLA) with a Buy rating and announces Price Target of C$3.5.

TSXV:VZLA

Credit Suisse Downgrades Yiren Digital to Underperform

Related Posts

Raymond James Maintains Outperform on ConnectOne Bancorp, Lowers Price Target to $33

KalVista Pharmaceuticals Announces Initiation Of KVD900 Phase 3 KONFIDENT Clinical Trial

Stifel Initiates Coverage On Travere Therapeutics with Hold Rating, Announces Price Target of $22

Stifel Initiates Coverage On Vizsla Silver with Buy Rating, Announces Price Target of C$3.5